Skip to content
value.today

Evio Pharmacy Solutions, LLC

🇺🇸 Denver, Colorado, USAHealth CareFounded 2020

Formerly KENT PHARMACY NEWCO, LLC

Total raised
$9 M
1 round on record
Latest round
$9 M
Feb 2025
First round on record
Feb 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Evio Pharmacy Solutions, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2025$9 MNo. 1$2 to $10 million

Evio Pharmacy Solutions, LLC: Raise no. 1, Feb 2025

Investors in this round

1 investor had bought by the notice of Mar 18, 2025: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Hank Schlissberg · Executive Officer
  • Helen E. Sherman · Executive Officer
  • Jeffrey A. Williams · Executive Officer
  • Deborah L. Johnson · Director
  • Juan A. Lopez · Director
  • Richard E. Lynch · Director
  • Susan E. Mullaney · Director
  • Todd E. Van Tol · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey A. Williams, General Counsel of Evio Pharmacy Solutions, LLC. Newest notice filed Mar 18, 2025. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Evio Pharmacy Solutions, LLC had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Mar 2025).

    SEC Form D (revenue range) · Mar 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Evio Pharmacy Solutions, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Evio Pharmacy Solutions, LLC
NameRoleNamed in
Hank SchlissbergExecutive officerMar 2025
Helen E. ShermanExecutive officerMar 2025
Jeffrey A. WilliamsExecutive officerMar 2025
Deborah L. JohnsonDirectorMar 2025
Juan A. LopezDirectorMar 2025
Richard E. LynchDirectorMar 2025
Susan E. MullaneyDirectorMar 2025
Todd E. Van TolDirectorMar 2025